| Summary points: | The authors discuss the effectiveness of near-infrared spectroscopy technology to monitor perfusion status in a combat setting using an FDA-approved device, the Inspectra 325 tissue oxygen saturation monitor, in conjunction with standard resuscitation and therapy of wounded patients presenting to the 228th Combat Support Hospital, Company B, over a 3-month period. |